Sava Healthcare

Executive Summary

Sava Healthcare Ltd is a private Indian pharmaceutical company established in 2003, operating as both a contract development and manufacturing organization (CDMO) and a proprietor of human, veterinary, and herbal medicine portfolios. Its WHO‑GMP and PIC/S certified facilities enable advanced drug delivery systems, including nasal sprays, dry‑powder inhalers, topical formulations, and a broad range of oral solid dosage forms. The company targets respiratory, allergy, dermatology, animal health, and Ayurvedic wellness markets. Leveraging cost‑effective manufacturing and regulatory compliance, Sava Healthcare serves as a strategic partner for global pharmaceutical firms seeking to outsource complex formulations. Its dual revenue stream from proprietary products and CDMO services provides resilience and growth potential in the expanding Indian pharma landscape. With increasing demand for inhalation and topical therapies, the company is well‑positioned to capture market share in both domestic and international markets.

Upcoming Catalysts (preview)

• Q3 2026New EU GMP certification for inhalation facility70% success
• Q2 2026Launch of first‑to‑market generic nasal spray in India60% success
• Q4 2026Partnership with multinational for dry‑powder inhaler CDMO50% success